American Assn for the Study of Liver Diseases

Based in VA

🤖

AI Overview

With $1.4M in lobbying spend across 28 quarterly filings, American Assn for the Study of Liver Diseases is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$1.4M
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$200K
2020$150K
2021$100K
2022$200K
2023$200K
2024$150K
2025$200K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues

Medicare reimbursement rates

MACRA Implementation, Chronic Care Reform

Liver Disease Research & Funding

H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018

Liver Disease Research & Funding

H.R.no bill #/S.3158 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019

Liver Disease Research & Funding

H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019.

Medicare reimbursement rates

MACRA Implementation Chronic Care Reform

Liver Disease Research & Funding

H.R. 6157 Department of Defense & Labor, Health & Human Services & Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019.

Liver Disease Research & Funding

HR 2740 Labor, HHS, Education, Defense, State, Foreign Operations and Energy and Water Development Appropriations Act, 2020

FDA guidance on Non-Alcoholic Steatohepatitis

Showing 8 of 19 unique descriptions from filings.

Related Analysis

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.